BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of Cytokine Modulators to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord Healthcare Ltd | 04596349 | ~£115,147 estimated from lot values | 2 lots Methotrexate pens (25mg/1ml concentration) · Methotrexate syringes (25mg/1 ml concentration) | - |
| Biogen Idec Ltd | 01497267 | ~£16,921,951 estimated from lot values | 2 lots Etanercept · Infliximab IV | LOBBYIST Portland PR Limited (2 quarters) Hawthorn Advisors Limited (1 quarter) |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£6,948,742 estimated from lot values | 2 lots Infliximab IV · Infliximab SC | - |
| Janssen Cilag Limited | 01027904 | ~£5,584,117 estimated from lot values | 1 lot Infliximab IV | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| medac Pharma LLP | OC415849 | ~£57,473 estimated from lot values | 1 lot Methotrexate pens (25mg/1ml concentration) | - |
| Nordic Pharma Ltd | 01489084 | ~£4,561,441 estimated from lot values | 2 lots Methotrexate pens (50mg/1 ml concentration) · Methotrexate syringes (50mg/1ml concentration) | - |
| Pfizer Ltd | 00526209 | ~£11,337,834 estimated from lot values | 1 lot Etanercept | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Sandoz | 01547204 | ~£11,337,834 estimated from lot values | 1 lot Etanercept | - |
This procurement was divided into 7 lots, each awarded separately. 12 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Etanercept 720 days (≈2 yrs) | £11,337,834 £1,700,000 initial term | 3 | Biogen Idec Ltd Sandoz Pfizer Ltd | active |
| Lot 2 Infliximab IV 720 days (≈2 yrs) | £5,584,117 £44,300,000 initial term | 4 | Celltrion Healthcare United Kingdom Limited Janssen Cilag Limited Biogen Idec Ltd Sandoz Ltd | active |
| Lot 3 Infliximab SC 720 days (≈2 yrs) | £1,364,625 £4,200,000 initial term | 1 single bid — no competition | Celltrion Healthcare United Kingdom Limited | active |
| Lot 4 Methotrexate syringes (25mg/1 ml concentration) 720 days (≈2 yrs) | £57,674 £577,000 initial term | 1 single bid — no competition | Accord Healthcare Ltd | active |
| Lot 5 Methotrexate pens (25mg/1ml concentration) 720 days (≈2 yrs) | £57,473 £5,150,000 initial term | 1 single bid — no competition | Accord Healthcare Ltd medac Pharma LLP | active |
| Lot 6 Methotrexate pens (50mg/1 ml concentration) 720 days (≈2 yrs) | £4,459,687 £1,000 initial term | 1 single bid — no competition | Nordic Pharma Ltd | active |
| Lot 7 Methotrexate syringes (50mg/1ml concentration) 720 days (≈2 yrs) | £101,754 £15,000 initial term | 1 single bid — no competition | Nordic Pharma Ltd | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £268,534,873 in 1,331 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust and 16 more public bodies (2010-08-03 to 2026-03-31).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.